Cargando…
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
Increased vascularization, also known as neoangiogenesis, plays a major role in many cancers, including glioblastoma multiforme (GBM), by contributing to their aggressive growth and metastasis. Although anti-angiogenic therapies provide some clinical improvement, they fail to significantly improve t...
Autores principales: | Izadpanah, Amin, Daneshimehr, Fatemeh, Willingham, Kurtis, Barabadi, Zahra, Braun, Stephen E., Dumont, Aaron, Mostany, Ricardo, Chandrasekar, Bysani, Alt, Eckhard U., Izadpanah, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421153/ https://www.ncbi.nlm.nih.gov/pubmed/36046049 http://dx.doi.org/10.3389/fonc.2022.893820 |
Ejemplares similares
-
TRAF3IP2, a novel therapeutic target in glioblastoma multiforme
por: Alt, Eckhard U., et al.
Publicado: (2018) -
Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer
por: Alt, Eckhard U., et al.
Publicado: (2020) -
Angiogenesis and Its Targeting in Glioblastoma with Focus
on Clinical Approaches
por: Daneshimehr, Fatemeh, et al.
Publicado: (2022) -
Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication
por: Scheller, Stefan H., et al.
Publicado: (2022) -
NPR3 protects cardiomyocytes from apoptosis through inhibition of cytosolic BRCA1 and TNF-α
por: Lin, Dong, et al.
Publicado: (2016)